» Articles » PMID: 24335741

American Society for Pain Management Nursing Position Statement: Pain Management in Patients with Substance Use Disorders

Overview
Journal J Addict Nurs
Specialties Nursing
Psychiatry
Date 2013 Dec 17
PMID 24335741
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The American Society for Pain Management Nursing (ASPMN) has updated its position statement on managing pain in patients with substance use disorders. This position statement is endorsed by the International Nurses Society on Addictions (IntNSA) and includes clinical practice recommendations based on current evidence. It is the position of ASPMN and IntNSA that every patient with pain, including those with substance use disorders, has the right to be treated with dignity, respect, and high-quality pain assessment and management. Failure to identify and treat the concurrent conditions of pain and substance use disorders will compromise the ability to treat either condition effectively. Barriers to caring for these patients include stigmatization, misconceptions, and limited access to providers skilled in these two categories of disorders. Topics addressed in this position statement include the scope of substance use and related disorders, conceptual models of addiction, ethical considerations, addiction risk stratification, and clinical recommendations.

Citing Articles

Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment.

Arnet I, Dursteler K, Jaiteh C, Grossmann F, Hersberger K Eur Addict Res. 2023; 29(4):253-263.

PMID: 37302389 PMC: 10614254. DOI: 10.1159/000530266.


A Scoping Review of Nursing's Contribution to the Management of Patients with Pain and Opioid Misuse.

Van Cleave J, Booker S, Powell-Roach K, Liang E, Kawi J Pain Manag Nurs. 2021; 22(1):58-68.

PMID: 33414010 PMC: 7887047. DOI: 10.1016/j.pmn.2020.11.007.


The Opioid Crisis and the Inpatient Floor: Considering Injection Drug Use in the Management of Infective Endocarditis and Acute Pain.

Mitchell L, Milliken A, Montgomery M, Singh S, Suzuki J Harv Rev Psychiatry. 2020; 28(5):334-340.

PMID: 32453063 PMC: 7492483. DOI: 10.1097/HRP.0000000000000259.


Comparison between intravenous morphine versus fentanyl in acute pain relief in drug abusers with acute limb traumatic injury.

Sheikh Motahar Vahedi H, Hajebi H, Vahidi E, Nejati A, Saeedi M World J Emerg Med. 2019; 10(1):27-32.

PMID: 30598715 PMC: 6264977. DOI: 10.5847/wjem.j.1920-8642.2019.01.004.


Incidence of Drug Abuse in Revision Total Knee Arthroplasty Population.

Roche M, Law T, Sodhi N, Rosas S, Kurowicki J, Disla S J Knee Surg. 2018; 31(10):928-933.

PMID: 30193389 PMC: 6427918. DOI: 10.1055/s-0038-1669915.


References
1.
Katz N, Adams E, Chilcoat H, Colucci R, Comer S, Goliber P . Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain. 2007; 23(8):648-60. DOI: 10.1097/AJP.0b013e318125c5e8. View

2.
Wesson D, Ling W . The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003; 35(2):253-9. DOI: 10.1080/02791072.2003.10400007. View

3.
Drew D, St Marie B . Pain in critically ill patients with substance use disorder or long-term opioid use for chronic pain. AACN Adv Crit Care. 2011; 22(3):238-54. DOI: 10.1097/NCI.0b013e318220c504. View

4.
Latimer W, Winters K, Stinchfield R . Screening for drug abuse among adolescents in clinical and correctional settings using the Problem-Oriented Screening Instrument for Teenagers. Am J Drug Alcohol Abuse. 1997; 23(1):79-98. DOI: 10.3109/00952999709001689. View

5.
Compton P, Darakjian J, Miotto K . Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage. 1999; 16(6):355-63. DOI: 10.1016/s0885-3924(98)00110-9. View